IMAX (IMAX) sale talks test appetite for premium cinema assets

IMAX Corp. (IMAX) has held “preliminary talks” with potential buyers through intermediaries, CNBC reported late Wednesday, reopening takeover speculation around a premium cinema company the market values at about $1.86 billion. Shares closed at $33.88, down 0.99 per cent on the day, according to Yahoo Finance market data. Behind the report sits a valuation question: what is a scaled large-format cinema asset worth in a deal market that still looks selective?

IMAX sits in a different lane from a standard theater operator. Instead, the company sells a premium screen brand, projection systems and a global exhibition network that can still command higher ticket prices when major studio releases hit. For buyers, that mix is the draw: a consumer entertainment brand with licensing and technology income layered on top of admissions.

At $33.88 a share and $1.86 billion in market value, IMAX is not priced like a distressed exhibitor. Yahoo Finance shows a forward price-to-earnings ratio of 17.37, while the fact bundle points to a trailing multiple above 50. Buyers, in other words, are being asked to underwrite earnings growth that has yet to fully arrive. So a control premium is possible if a real process develops. Even so, disappointment remains possible if the talks go nowhere.

Operating results help explain why. CNBC said the company generated a record $1.28 billion in global box office in 2025, while latest annual revenue was about $410.2 million according to Yahoo Finance financials. Those figures support the view that IMAX is less a cyclical theater bet than a premium media-infrastructure business with a global brand.

On that view, a $1.86 billion equity value is about 4.5 times latest annual revenue, rich for a conventional exhibitor but less unusual for a company that also sells technology and licensing. A cinema chain screens films. IMAX sells a format.

Why buyers care

Across this year’s M&A market, exploratory conversations still look more common than signed deals. The Financial Times reported this week that Estée Lauder and Puig ended merger talks, a reminder that corporate interest and execution are not the same thing. Earlier this month, the Guardian reported that Hiscox shares jumped on a takeover approach, another example of recognizable assets drawing attention in an uneven market. IMAX fits that pattern: distinctive enough to attract interest, niche enough to support a premium, yet still exposed to the stop-start rhythm of 2026 dealmaking.

From a buyer’s perspective, the attraction is straightforward. IMAX offers an installed base, studio relationships and a consumer brand with global reach rather than a greenfield rollout. It also brings technology and licensing income that ordinary exhibitors do not have. Legible assets matter in a choosier market.

Still, the market is unlikely to treat the story as a done deal. CNBC described only preliminary talks, and early outreach often says more about appetite testing than about final terms. One acquirer may see room to expand the premium-screen network or deepen licensing economics. Another may decide the current valuation already captures much of that upside. Cash conversion, growth visibility and the repeatability of premium box-office performance will matter in any model.

Such caution helps explain the muted share move. IMAX closed lower on the day even with the CNBC report in the market, suggesting investors still see a gap between exploratory interest and a financed offer. Buyers want evidence. Curiosity is not enough.

What comes next

What comes next is process: broader buyer outreach, management commentary on strategy, or a share price that starts to carry a clearer takeover premium. Until then, the episode looks more like a test of what premium cinema assets can command in a selective market than a sale nearing the finish line. For bankers and private-equity desks, IMAX offers a read-through on how investors value branded experiential assets with some technology DNA. If interest progresses, scarcity arguments get stronger. If it fades, the market will still learn where the ceiling for niche media valuations may sit.